Camilla Rasmussen

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment

Duncan J. Stewart, Jennifer M. Arnold, Jean‐Claude Grégoire et al. · Gene Therapy · 2006 · 283 citations

Medicine, Cardiology, Clinical Sciences +14

TNFerade Biologic, an Adenovector With a Radiation-Inducible Promoter, Carrying the Human Tumor Necrosis Factor Alpha Gene: A Phase I Study in Patients With Solid Tumors

Neil Senzer, Sridhar Mani, Alexander S. Rosemurgy et al. · Journal of Clinical Oncology · 2004 · 196 citations · Full text

Medicine, Oncology, Radiation Oncology +14

A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities

Arno J. Mundt, Srinivasan Vijayakumar, John Nemunaitis et al. · Clinical Cancer Research · 2004 · 87 citations

Medicine, Oncology, Radiation Oncology +11

TNFerade Biologic: Preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene

Henrik Rasmussen, Camilla Rasmussen, Maria Lempicki et al. · Cancer Gene Therapy · 2002 · 80 citations

Medicine, Oncology, Toxicology +15

In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS‐275 in retinoid‐resistant prostate cancer cells

David Z. Qian, Mingqiang Ren, Yongfeng Wei et al. · The Prostate · 2005 · 36 citations · Full text

Medicine, Molecular Biology, Oncology +17